Thursday, May 26, 2022 10:27:37 AM
Huge news just released from $RVVTF: Furthermore, The FDA has agreed that the Company may unblind the pre-dose-selection data for the first 210 patients of the Study to further support the new primary endpoint. Massive!https://t.co/Hz6PRlITW1 pic.twitter.com/mHEXCL6RwJ
— The Dales Report (@TheDalesReport) May 26, 2022
Reddit post thread here. https://www.reddit.com/r/RVVTF/comments/uy8nem/revive_therapeutics_provides_update_on_phase_3/?utm_medium=android_app&utm_source=share
Ps. Time to clock in work...
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM